Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

, P. G. Corrie (Lead / Corresponding author), A. Marshall, P. D. Nathan, P. Lorigan, M. Gore, S. Tahir, G. Faust, C. G. Kelly, M. Marples, S. J. Danson, E. Marshall, S. J. Houston, R. E. Board, A. M. Waterston, J. P. Nobes, M. Harries, S. Kumar, A. Goodman, A. DalgleishA. Martin-Clavijo, S. Westwell, R. Casasola, D. Chao, A. Maraveyas, P. M. Patel, C. H. Ottensmeier, D. Farrugia, A. Humphreys, B. Eccles, G. Young, E. O. Barker, C. Harman, M. Weiss, K. A. Myers, A. Chhabra, S. H. Rodwell, J. A. Dunn, M. R. Middleton

    Research output: Contribution to journalArticlepeer-review

    44 Citations (Scopus)
    125 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences